Iscalimab (CD40/TNFRSF5) - Research Grade Biosimilar

Iscalimab (CFZ533) is fully human monoclonal antibody targeting differentiation cluster 40 (CD40), which cy pathway, preventing CD40 pathway signaling and CD40 + cell type activation It has become a new therapy for the treatment of solid organs and related autoimmune diseases.

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8 ˚ C for 1-2 weeks. Store at -20 ˚ C for 12 months. Store at -80 ˚ C for long term storage.